Your browser doesn't support javascript.
loading
Capillary Electrophoresis-Mass Spectrometry at Trial by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible and Robust Compound Annotation.
Drouin, Nicolas; van Mever, Marlien; Zhang, Wei; Tobolkina, Elena; Ferre, Sabrina; Servais, Anne-Catherine; Gou, Marie-Jia; Nyssen, Laurent; Fillet, Marianne; Lageveen-Kammeijer, Guinevere S M; Nouta, Jan; Chetwynd, Andrew J; Lynch, Iseult; Thorn, James A; Meixner, Jens; Lößner, Christopher; Taverna, Myriam; Liu, Sylvie; Tran, N Thuy; Francois, Yannis; Lechner, Antony; Nehmé, Reine; Al Hamoui Dit Banni, Ghassan; Nasreddine, Rouba; Colas, Cyril; Lindner, Herbert H; Faserl, Klaus; Neusüß, Christian; Nelke, Manuel; Lämmerer, Stefan; Perrin, Catherine; Bich-Muracciole, Claudia; Barbas, Coral; Gonzálvez, Ángeles López; Guttman, Andras; Szigeti, Marton; Britz-McKibbin, Philip; Kroezen, Zachary; Shanmuganathan, Meera; Nemes, Peter; Portero, Erika P; Hankemeier, Thomas; Codesido, Santiago; González-Ruiz, Víctor; Rudaz, Serge; Ramautar, Rawi.
Afiliação
  • Drouin N; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands.
  • van Mever M; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands.
  • Zhang W; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands.
  • Tobolkina E; School of Pharmaceutical Sciences, University of Geneva, Rue Michel Servet 1, 1211 4 Geneva, Switzerland.
  • Ferre S; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel Servet 1, 1211 4 Geneva, Switzerland.
  • Servais AC; School of Pharmaceutical Sciences, University of Geneva, Rue Michel Servet 1, 1211 4 Geneva, Switzerland.
  • Gou MJ; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel Servet 1, 1211 4 Geneva, Switzerland.
  • Nyssen L; Laboratory for the Analysis of Medicines, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Avenue Hippocrate 15, B-4000 Liège, Belgium.
  • Fillet M; Laboratory for the Analysis of Medicines, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Avenue Hippocrate 15, B-4000 Liège, Belgium.
  • Lageveen-Kammeijer GSM; Laboratory for the Analysis of Medicines, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Avenue Hippocrate 15, B-4000 Liège, Belgium.
  • Nouta J; Department of Clinical Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Avenue Hippocrate 15, B-4000 Liège, Belgium.
  • Chetwynd AJ; Laboratory for the Analysis of Medicines, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Avenue Hippocrate 15, B-4000 Liège, Belgium.
  • Lynch I; Leiden University Medical Center, Center for Proteomics and Metabolomics, 2300 RC Leiden, The Netherlands.
  • Thorn JA; Leiden University Medical Center, Center for Proteomics and Metabolomics, 2300 RC Leiden, The Netherlands.
  • Meixner J; School of Geography Earth and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
  • Lößner C; School of Geography Earth and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
  • Taverna M; AB Sciex UK Ltd, Phoenix House, Lakeside Drive, Warrington, Cheshire WA1 1RX, U.K.
  • Liu S; Agilent Technologies R&D and Marketing GmbH & Co. KG, Hewlett-Packard-Straße 8, 76337 Waldbronn, Germany.
  • Tran NT; AB Sciex, Landwehrstrasse 54, 64293 Darmstadt, Germany.
  • Francois Y; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
  • Lechner A; Institut Universitaire de France, 1 Rue Descartes, 75231 CEDEX 05 Paris, France.
  • Nehmé R; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
  • Al Hamoui Dit Banni G; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
  • Nasreddine R; Laboratoire de Spectromètrie de Masse des Interactions et des Systémes (LSMIS) UMR 7140 (Unistra-CNRS), Université de Strasbourg, 4 Rue Blaise Pascal, 67081 CEDEX Strasbourg, France.
  • Colas C; Laboratoire de Spectromètrie de Masse des Interactions et des Systémes (LSMIS) UMR 7140 (Unistra-CNRS), Université de Strasbourg, 4 Rue Blaise Pascal, 67081 CEDEX Strasbourg, France.
  • Lindner HH; Institut de Chimie Organique et Analytique (ICOA), CNRS FR 2708 - UMR 7311, Université d'Orléans, 45067 Orléans, France.
  • Faserl K; Institut de Chimie Organique et Analytique (ICOA), CNRS FR 2708 - UMR 7311, Université d'Orléans, 45067 Orléans, France.
  • Neusüß C; Institut de Chimie Organique et Analytique (ICOA), CNRS FR 2708 - UMR 7311, Université d'Orléans, 45067 Orléans, France.
  • Nelke M; Institut de Chimie Organique et Analytique (ICOA), CNRS FR 2708 - UMR 7311, Université d'Orléans, 45067 Orléans, France.
  • Lämmerer S; Centre de Biophysique Moléculaire, CNRS-Université d'Orléans, UPR 4311, 45071 CEDEX 2 Orléans, France.
  • Perrin C; Institute of Clinical Biochemistry, Innsbruck Medical University, Innrain 80-82, A-6020 Innsbruck, Austria.
  • Bich-Muracciole C; Institute of Clinical Biochemistry, Innsbruck Medical University, Innrain 80-82, A-6020 Innsbruck, Austria.
  • Barbas C; Faculty of Chemistry, Aalen University, Beethovenstraße 1, 73430 Aalen, Germany.
  • Gonzálvez ÁL; Faculty of Chemistry, Aalen University, Beethovenstraße 1, 73430 Aalen, Germany.
  • Guttman A; Faculty of Chemistry, Aalen University, Beethovenstraße 1, 73430 Aalen, Germany.
  • Szigeti M; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247-CNRS-UM-ENSCM, Université de Montpellier, 34093 CEDEX 5 Montpellier, France.
  • Britz-McKibbin P; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247-CNRS-UM-ENSCM, Université de Montpellier, 34093 CEDEX 5 Montpellier, France.
  • Kroezen Z; Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilladel Monte 28660, Madrid, Spain.
  • Shanmuganathan M; Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilladel Monte 28660, Madrid, Spain.
  • Nemes P; Horváth Csaba Memorial Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Faculty of Medicine, Doctoral School of Molecular Medicine, University of Debrecen, 98 Nagyerdei Road, H-4032 Debrecen, Hungary.
  • Portero EP; Translation Glycomics Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10 Egyetem Street, Veszprem H-8200, Hungary.
  • Hankemeier T; Sciex, 250 South Kraemer Boulevard, Brea, California 92821, United States.
  • Codesido S; Horváth Csaba Memorial Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Faculty of Medicine, Doctoral School of Molecular Medicine, University of Debrecen, 98 Nagyerdei Road, H-4032 Debrecen, Hungary.
  • González-Ruiz V; Translation Glycomics Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10 Egyetem Street, Veszprem H-8200, Hungary.
  • Rudaz S; Department of Chemistry and Chemical Biology, McMaster University, 1280 Main St. W., Hamilton, Ontario L8S 4M1, Canada.
  • Ramautar R; Department of Chemistry and Chemical Biology, McMaster University, 1280 Main St. W., Hamilton, Ontario L8S 4M1, Canada.
Anal Chem ; 92(20): 14103-14112, 2020 10 20.
Article em En | MEDLINE | ID: mdl-32961048
ABSTRACT
Capillary zone electrophoresis-mass spectrometry (CE-MS) is a mature analytical tool for the efficient profiling of (highly) polar and ionizable compounds. However, the use of CE-MS in comparison to other separation techniques remains underrepresented in metabolomics, as this analytical approach is still perceived as technically challenging and less reproducible, notably for migration time. The latter is key for a reliable comparison of metabolic profiles and for unknown biomarker identification that is complementary to high resolution MS/MS. In this work, we present the results of a Metabo-ring trial involving 16 CE-MS platforms among 13 different laboratories spanning two continents. The goal was to assess the reproducibility and identification capability of CE-MS by employing effective electrophoretic mobility (µeff) as the key parameter in comparison to the relative migration time (RMT) approach. For this purpose, a representative cationic metabolite mixture in water, pretreated human plasma, and urine samples spiked with the same metabolite mixture were used and distributed for analysis by all laboratories. The µeff was determined for all metabolites spiked into each sample. The background electrolyte (BGE) was prepared and employed by each participating lab following the same protocol. All other parameters (capillary, interface, injection volume, voltage ramp, temperature, capillary conditioning, and rinsing procedure, etc.) were left to the discretion of the contributing laboratories. The results revealed that the reproducibility of the µeff for 20 out of the 21 model compounds was below 3.1% vs 10.9% for RMT, regardless of the huge heterogeneity in experimental conditions and platforms across the 13 laboratories. Overall, this Metabo-ring trial demonstrated that CE-MS is a viable and reproducible approach for metabolomics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Orgânicos / Eletroforese Capilar / Espectrometria de Massas em Tandem Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Anal Chem Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Orgânicos / Eletroforese Capilar / Espectrometria de Massas em Tandem Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Anal Chem Ano de publicação: 2020 Tipo de documento: Article